Company: NIVFW
Filing Date: 2025-04-22
Form Type: 20-F
Source: 0001213900-25-033966
Chunk: 145

Company: NewGenIvf Group Ltd
Filing Date: 2025-04-22
Form: 20-F
Item: Item 19
Chunk 145
---
 this annual report on its behalf.

  Signature                     Title                                                               Date            
  /s/ Wing Fung Alfred Siu      Chairman, Chief Executive Officer                                   April 22, 2025  
 ────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
  Wing Fung Alfred Siu          (Principal Executive Officer and Duly Authorized Officer)                           
  /s/ Ho Fai Chung              Chief Financial Officer                                             April 22, 2025  
  Ho Fai Chung                  (Principal Financial Officer and Principal Accounting Officer)                      

NEWGENIVF LIMITED

  AUDITED CONSOLIDATED FINANCIAL STATEMENTS                                                                                            
  Report of Independent Registered Public Accounting Firm (PCAOB ID: 6732)                                                        F-2  
  Report of Independent Registered Public Accounting Firm (PCAOB ID: 6743)                                                        F-3  
  Consolidated Balance Sheets as of December 31, 2024 and 2023                                                                    F-4  
  Consolidated Statements of Operations and Comprehensive Income (Loss) for the Years Ended December 31, 2024, 2023 and 2022      F-5  
  Consolidated Statements of Changes in Shareholders’ Equity (Deficit) for the Years Ended December 31, 2024, 2023 and 2022       F-6  
  Consolidated Statements of Cash Flows for the Years Ended December 31, 2024, 2023 and 2022                                      F-7  
  Notes to the Consolidated Financial Statements                                                                                  F-8  

F-1

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING
FIRM

  To:      The Board of Directors and Shareholders of NewgenIvf Limited  

Opinion on the Financial Statements

We have audited the accompanying
consolidated balance sheet of NewgenIvf Limited and its subsidiaries (collectively, the “ Company”) as of December 31, 2023,
the related consolidated statements of operations and comprehensive income, shareholders’ equity, and cash flows for the year ended
December 31, 2023, and the related notes to the consolidated financial statements and schedule (collectively, the financial statements).
In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December
31, 2023, and the results of its operations and its cash flows for the year ended December 31, 2023, in conformity with accounting principles